These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 4272676

  • 1. Red cell size and uric acid in Down's syndrome.
    Howell A, Mason AS, Brown E, Watts RW, Chanarin I, McPherson K, Ridler MA.
    Scand J Haematol; 1973; 11(2):140-7. PubMed ID: 4272676
    [No Abstract] [Full Text] [Related]

  • 2. Leucocyte ultrastructure and folate metabolism in Down's syndrome.
    Gericke GS, Hesseling PB, Brink S, Tiedt FC.
    S Afr Med J; 1977 Mar 19; 51(12):369-74. PubMed ID: 139696
    [Abstract] [Full Text] [Related]

  • 3. Hyperuricemia in Down's syndrome.
    Pant SS, Moser HW, Krane SM.
    J Clin Endocrinol Metab; 1968 Apr 19; 28(4):472-8. PubMed ID: 4230664
    [No Abstract] [Full Text] [Related]

  • 4. Renal impairment in urate excretion in patients with Down's syndrome.
    Nishida Y, Akaoka I, Kobayashi M, Maruki K, Oshima Y.
    J Rheumatol; 1979 Apr 19; 6(1):103-7. PubMed ID: 155745
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neurologic aspects of typical and atypical Down's syndrome.
    Paulson GW, Nance W, Son C.
    Neurology; 1968 Mar 19; 18(3):305-6. PubMed ID: 4231810
    [No Abstract] [Full Text] [Related]

  • 7. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S.
    Pediatr Pol; 1995 Jun 19; 70(6):467-71. PubMed ID: 8692603
    [Abstract] [Full Text] [Related]

  • 8. [Hyperuricemia in Down's syndrome (etiology, significance, and possibilities of its modification)].
    Kucera J.
    Cesk Pediatr; 1976 Jun 19; 31(6):316-9. PubMed ID: 134841
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Macrocytosis in Down's syndrome and during long-term anticonvulsant therapy.
    Eastham RD, Jancar J.
    J Clin Pathol; 1970 May 19; 23(4):296-8. PubMed ID: 4246925
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Probable reciprocal translocation in somatic cells from patients with Down's syndrome.
    Sonta S, Oishi H.
    Jinrui Idengaku Zasshi; 1974 Sep 19; 19(2):169-73. PubMed ID: 4280457
    [No Abstract] [Full Text] [Related]

  • 14. Clearance of uric acid, urea, and creatinine in Down's syndrome.
    Coburn SP, Seidenberg M, Mertz ET.
    J Appl Physiol; 1967 Oct 19; 23(4):579-80. PubMed ID: 4228269
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Cytogenetic studies of families of patients with Down's syndrome].
    Davidenkova EF, Kolosova NN, Pantova IG, Shushval ON.
    Tsitologiia; 1966 Oct 19; 8(2):277-82. PubMed ID: 4228480
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A boy with Down's syndrome having recombinant chromosome 21 but no SOD-1 excess.
    Miyazaki K, Yamanaka T, Ogasawara N.
    Clin Genet; 1987 Dec 19; 32(6):383-7. PubMed ID: 2963715
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.